(Q44422796)

English

Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy (English)

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

0 references

Adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

author name string

North Central Cancer Treatment Group

14

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Timothy F. Kozelsky

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Gregory E. Meyers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Jeff A. Sloan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Thomas G. Shanahan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Stephen J. Dick

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Randy L. Moore

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

George P. Engeler

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Albert R. Frank

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Timothy K. McKone

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Rodolfo E. Urias

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Miljenko V. Pilepich

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

Paul J. Novotny

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

James A. Martenson

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721240

28 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.05.060

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1669-1674

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.

1

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial

2

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

3

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy

5

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Glutamine utilization by the small intestine.

6

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Intestinal consumption of intravenously administered fuels

7

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition

8

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Prophylactic glutamine protects the intestinal mucosa from radiation injury

9

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation

10

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Prevention of chronic radiation enteropathy by dietary glutamine

11

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

L-glutamine enemas attenuate mucosal injury in experimental colitis

12

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury

13

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

The incidence and clinical consequences of treatment-related bowel injury

14

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander

15

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation

16

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function

17

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial

18

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer

19

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Quality of life research in oncology. Past achievements and future priorities

22

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective

23

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer

24

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial

25

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy

27

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation

28

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

29

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Glutamine treatment of paclitaxel-induced myalgias and arthralgias

30

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study

31

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial

32

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer

33

1 reference

10.1200/JCO.2003.05.060

https://api.crossref.org/works/10.1200/JCO.2003.05.060

28 December 2023

Identifiers

10.1200/JCO.2003.05.060

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44422796&oldid=2039405931"